Journal of Translational Medicine (Oct 2021)
Correction to: Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer
- Dan Wang,
- Weitang Yuan,
- Yaping Wang,
- Qian Wu,
- Li Yang,
- Feng Li,
- Xinfeng Chen,
- Zhen Zhang,
- Weina Yu,
- Nomathamsanqa Resegofetse Maimela,
- Ling Cao,
- Dong Wang,
- Junxia Wang,
- Zhenqiang Sun,
- Jinbo Liu,
- Yi Zhang
Affiliations
- Dan Wang
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University
- Weitang Yuan
- Department of Anorectal Surgery, The First Affiliated Hospital of Zhengzhou University
- Yaping Wang
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University
- Qian Wu
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University
- Li Yang
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University
- Feng Li
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University
- Xinfeng Chen
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University
- Zhen Zhang
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University
- Weina Yu
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University
- Nomathamsanqa Resegofetse Maimela
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University
- Ling Cao
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University
- Dong Wang
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University
- Junxia Wang
- Department of Gastrointestinal Surgery, The First Affiliated Hospital of Zhengzhou University
- Zhenqiang Sun
- Department of Anorectal Surgery, The First Affiliated Hospital of Zhengzhou University
- Jinbo Liu
- Department of Anorectal Surgery, The First Affiliated Hospital of Zhengzhou University
- Yi Zhang
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University
- DOI
- https://doi.org/10.1186/s12967-021-03107-7
- Journal volume & issue
-
Vol. 19,
no. 1
pp. 1 – 4
Abstract
No abstracts available.